IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 5, 2014, Pages 403-413

  Klang, Andrea ^a   Schmidt, Peter ^a   Kneissl, Sibylle ^a   Bagó, Zoltán ^c   Vincent, Angela ^d   Lang, Bethan ^d   Moloney, Teresa ^d   Bien, Christian G ^e   Halász, Péter ^f   Bauer, Jan ^b   Pákozdy, Ákos ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Medical University of Vienna   (Austria)

^c AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e EPILEPSY CENTER BETHEL   (Germany)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Cat; Epilepsy; Feline complex partial cluster seizures with orofacial involvement; hippocampal necrosis; Limbic encephalitis; Voltage gated potassium channel complex

Indexed keywords

IMMUNOGLOBULIN G; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; COMPLEMENT DEPOSITION; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; EPILEPSY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEPOSITION; NERVE CELL LESION; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; AUTOANTIBODIES; CATS; CELL COUNT; CELL DEATH; COMPLEMENT SYSTEM PROTEINS; EPILEPSY; HIPPOCAMPUS; HUMANS; IMMUNOGLOBULIN G; NEURONS; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 84899586852     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000063     Document Type: Article

References (45)

1. Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: New developments and future challenges. Lancet Neurol 2011;10:759-72
2. Graus F, Dalmau J. CNS autoimmunity: New findings and pending issues. Lancet Neurol 2012;11:17-19
3. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: Clues for pathogenesis. Brain 2012;135:1622-38
4. Lancaster E, Dalmau J. Neuronal autoantigens-Pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012;8:380-90
5. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibodyassociated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12
6. Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67: 470-78
7. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74
8. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-17
9. Vincent A, Irani SR, Lang B. The growing recognition of immunotherapy responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 2010;23:144-50
10. Frisch C, Malter MP, Elger CE, et al. Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis. Eur J Neurol 2013;20:1297-304
11. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69: 303-11
12. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series. Lancet Neurol 2010;9:776-85
13. v1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-48
14. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892-900
15. Wong SH, Saunders MD, Larner AJ, et al. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 2010;81:1167-69
16. Fatzer R, Gandini G, Jaggy A, et al. Necrosis of hippocampus and piriform lobe in 38 domestic cats with seizures: A retrospective study on clinical and pathologic findings. J Vet Intern Med 2000;14:100-4
17. Brini E, Gandini G, Crescio I, et al. Necrosis of hippocampus and piriform lobe: Clinical and neuropathological findings in two Italian cats. J Feline Med Surg 2004;6:377-81
18. Schmied O, Scharf G, Hilbe M, et al. Magnetic resonance imaging of feline hippocampal necrosis. Vet Radiol Ultrasound 2008;49:343-49
19. Gelberg HB. Diagnostic exercise: Sudden behavior change in a cat. Vet Pathol 2013;50:1156-57
20. Yanai H, Palus V, Caine A, Summers B, et al. Feline idiopathic hippocampal necrosis: Findings in a UK case. Vet Times 2013;11:19-20
21. Pakozdy A, Gruber A, Kneissl S, et al. Complex partial cluster seizures in cats with orofacial involvement. J Feline Med Surg 2011;13:687-93
22. Marioni-Henry K, Monteiro R, Behr S. Complex partial orofacial seizures in English cats. Vet Rec 2012;170:471
23. Pakozdy A, Halasz P, Klang A, et al. Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody. J Vet Int Med 2013;27:212-14
24. Muller GJ, Stadelmann C, Bastholm L, et al. Ischemia leads to apoptosisand necrosis-like neuron death in the ischemic rat hippocampus. Brain Pathol 2004;14:415-24
25. Vanhaesebrouck AE, Posch B, Baker S, et al. Temporal lobe epilepsy in a cat with a pyriform lobe oligodendroglioma and hippocampal necrosis. J Feline Med Surg 2012;14:932-37
26. Schmidt-Kastner R, Ophoff BG, Hossmann KA. Pattern of neuronal vulnerability in the cat hippocampus after one hour of global cerebral ischemia. Acta Neuropathol 1990;79:444-55
27. Jurk IR, Thibodeau MS, Whitney K, et al. Acute vision loss after general anesthesia in a cat. Vet Ophthalmol 2001;4:155-58
28. Altay UM, Skerritt GC, Hilbe M, et al. Feline cerebrovascular disease: Clinical and histopathologic findings in 16 cats. J Am Anim Hosp Assoc 2011;47:89-97
29. Tanaka T, Kaijima M, Daita G, et al. Electroclinical features of kainic acid-induced status epilepticus in freely moving cats. Microinjection into the dorsal hippocampus. Electroencephalogr Clin Neurophysiol 1982;54: 288-300
30. Dunstan EJ, Winer JB. Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. Age Ageing 2006;35: 536-37
31. Park DC, Murman DL, Perry KD, et al. An autopsy case of limbic encephalitis with voltage-gated potassium channel antibodies. Eur J Neurol 2007;14:e5-e6
32. Khan NL, Jeffree MA, Good C, et al. Histopathology of VGKC antibody-associated limbic encephalitis. Neurology 2009;72:1703-5
33. Szepietowski JC, Nilganuwong S, Wozniacka A, et al. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus. Arthritis Rheum 2013;65:2661-71
34. Reid JM, Foley P, Willison HJ. Voltage-gated potassium channel-associated limbic encephalitis in the West of Scotland: Case reports and literature review. Scott Med J 2009;54:27-31
35. Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013;136:3151-62
36. Tuzun E, Zhou L, Baehring JM, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009;118:737-43
37. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, et al. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011;77:589-93
38. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurol 2013;12:157-65
39. Bauer J, Vezzani A, Bien CG. Epileptic encephalitis: The role of the innate and adaptive immune system. Brain Pathol 2012;22:412-21
40. Drachman DB, Angus CW, Adams RN, et al. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978;298:1116-22
41. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-98
42. Pohl M, Kawakami N, Kitic M, et al. T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol Commun 2013;1:85
43. + T-cells as regulators of CNS vascular permeability. Neurol Res 2006;28:250-55
44. Irani SR, Vincent A. Autoimmune encephalitis-New awareness, challenging questions. Discov Med 2011;11:449-58
45. Blumcke I, Spreafico R. Cause matters: A neuropathological challenge to human epilepsies. Brain Pathol 2012;22:347-49